Trudi Haemmerli

Trudi is always looking to add value to the world, particularly in the innovation of our healthcare, and a greater diversity of gender and talent in the teams pursuing these goals. Trudi spent over 25 years in the pharmaceutical industry primarily in Global Research & Development roles in Basel and Boston. After completing her MBA in St. Gallen she left the corporate world to join a life science startup as CEO. As a Business Angel investor and Venture Partner, Trudi also invests in, and consults, early stage startups. She joined the Board of Innosuisse – the Swiss Innovation Agency – in 2017 and is President of the Swiss Health Angels Business Angel Club.